You have absolutely no idea what is the Oncosil device. It is an implantable device via an endoscopy. How do you insert a placebo device via endoscopy and compare that with SOC treatment?
You and all the other naysayers are confusing the placebo effect of the trial when you are dealing with an implantable device. This is not a drug or tablet. Nor is it like Sirtex which is injectable, like all of the naysayers shareholders have suggested.
Go away and play with your competitor cancer investments. You and the other naysayers are afraid that Oncosil will prevail and bite into the competition. Don’t be so greedy. There is more than enough in the cancer drug/device/injectable space to go around.
OSL Price at posting:
12.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)